Related Experiment Videos
[Percutaneous balloon valvuloplasty in mitral stenosis]
U Zeymer1, A Vogt, K L Neuhaus
1Medizinische Klinik II, Städtische Kliniken Kassel.
Deutsche Medizinische Wochenschrift (1946)
|May 3, 1991
Summary
Percutaneous balloon valvuloplasty (PBV) effectively treated mitral stenosis in 50 patients, improving hemodynamics and avoiding surgery for many. Medium-term follow-up showed sustained clinical benefits in most patients, demonstrating PBV
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral stenosis is a significant valvular heart disease.
- Percutaneous balloon valvuloplasty (PBV) offers a less invasive treatment option.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous balloon valvuloplasty (PBV) for mitral stenosis.
- To assess the medium-term clinical and hemodynamic outcomes of PBV.
Main Methods:
- PBV was performed using a transseptal, single-balloon technique in 50 consecutive patients.
- Technical success, procedural complications, and immediate hemodynamic changes were recorded.
- Clinical and hemodynamic outcomes were assessed during a mean follow-up of 14 months.
Main Results:
- PBV was technically successful in 48 patients.
- Significant improvements were observed in diastolic gradient, pulmonary artery pressure, and valve opening area.
- 30 of 33 patients without further intervention showed stable clinical improvement and hemodynamic findings at follow-up.
Conclusions:
- PBV is an effective treatment for mitral stenosis, providing significant hemodynamic improvement.
- The procedure offers medium-term clinical benefits in approximately two-thirds of patients, potentially avoiding surgery.
- PBV is a safe and viable alternative for selected patients with mitral stenosis.